• Latest Posts

Intravacc to develop intranasal gonorrhea vaccine with $14.6M NIH/NIAID contract

Startup Scout 7 Jul 2017

A Norwegian Biotech is Aiming at Permanently Removing HPV Skin Infections

Results are in for Europe’s First Biobanking Study on HPV Cervical Cancer

€4M Grant for a Cancer Vaccine that could Bench its Competitors

Transgene teams up with big Players against HPV Head and Neck Cancer


After its drop earlier this year, Genticel goes back up the slope

Genticel is vaccinating against Cervical Cancer AFTER Infection

Viral Immunotherapy Trial Failure Causes French Biotech Stocks to Drop 43%

The Assault on Solid Tumors: How ‘Blinding’ Cancer is an Attractive Therapeutic Approach

Genticel aims to prevent Cancer caused by the Human Papillomavirus